Patient Preference and Time Allocation Associated with Transition from Intravenous to Subcutaneous Administration of Natalizumab (Tysabri) in Patients with Relapsing Remitting MS – A Questionnaire Study

Anna Almroth, Karin Söderbärg, Irina Sjöblom · 2025

Read Patient Preference and Time Allocation Associated with Transition from Intravenous to Subcutaneous Administration of Natalizumab (Tysabri) in Patients with Relapsing Remitting MS – A Questionnaire Study by Anna Almroth, Karin Söderbärg, Irina Sjöblom (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743484.txt.

Description

Anna Almroth, Karin Soderbarg, and Irina Sjoblom survey patients and staff on a switch in how a multiple sclerosis drug is given. Their 2025 study covers eighty-three patients and fourteen staff at five Swedish hospitals. All had known both drip dosing in hospital and skin shots, which can move to local clinics.

Shots took far less time: most patients spent half an hour or less, against one to two hours for drips. In local clinics most shots wrapped in under fifteen minutes. Four in five patients favored shots, and staff found prep quicker with smoother flow. Work life suffered less with clinic shots. Both sides called the switch easy to handle.

Catalog record

CREATORAnna Almroth, Karin Söderbärg, Irina Sjöblom
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12743484

Browse the full library · About the Tower of Babel